GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » ROA %

Kingworld Medicines Group (HKSE:01110) ROA % : 4.28% (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Kingworld Medicines Group's annualized Net Income for the quarter that ended in Jun. 2024 was HK$66 Mil. Kingworld Medicines Group's average Total Assets over the quarter that ended in Jun. 2024 was HK$1,545 Mil. Therefore, Kingworld Medicines Group's annualized ROA % for the quarter that ended in Jun. 2024 was 4.28%.

The historical rank and industry rank for Kingworld Medicines Group's ROA % or its related term are showing as below:

HKSE:01110' s ROA % Range Over the Past 10 Years
Min: 0.95   Med: 2.98   Max: 4.29
Current: 2.19

During the past 13 years, Kingworld Medicines Group's highest ROA % was 4.29%. The lowest was 0.95%. And the median was 2.98%.

HKSE:01110's ROA % is ranked better than
55.15% of 680 companies
in the Healthcare Providers & Services industry
Industry Median: 1.405 vs HKSE:01110: 2.19

Kingworld Medicines Group ROA % Historical Data

The historical data trend for Kingworld Medicines Group's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group ROA % Chart

Kingworld Medicines Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.34 0.95 2.50 1.75 2.90

Kingworld Medicines Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 -0.23 5.67 0.05 4.28

Competitive Comparison of Kingworld Medicines Group's ROA %

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingworld Medicines Group's ROA % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's ROA % distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's ROA % falls into.



Kingworld Medicines Group ROA % Calculation

Kingworld Medicines Group's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=41.669/( (1410.816+1463.093)/ 2 )
=41.669/1436.9545
=2.90 %

Kingworld Medicines Group's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=66.134/( (1463.093+1627.32)/ 2 )
=66.134/1545.2065
=4.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Kingworld Medicines Group  (HKSE:01110) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=66.134/1545.2065
=(Net Income / Revenue)*(Revenue / Total Assets)
=(66.134 / 1132.714)*(1132.714 / 1545.2065)
=Net Margin %*Asset Turnover
=5.84 %*0.7331
=4.28 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Kingworld Medicines Group ROA % Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Executives
Chan Lok San 2101 Beneficial owner
Zhao Li Sheng 2101 Beneficial owner
Sinopharm Capital Limited 2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p. 2101 Beneficial owner
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you

Kingworld Medicines Group Headlines

No Headlines